Low Debt, High Growth Potential, A Smart Buy?
A niche API and pharmaceutical intermediates manufacturer with global regulatory approvals, strong R&D capabilities, and expanding manufacturing capacity – but how resilient and scalable is its revenue model? Anlon Healthcare IPO review will clear all your doubts. The Indian pharmaceutical industry is undergoing a structural shift. With rising demand for APIs (Active Pharmaceutical Ingredients), growing […]










